Day: May 28, 2025

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM), announced today that the Toronto Stock Exchange (the “TSX”) has approved its notice of intention to commence a normal course issuer bid (“NCIB”) for its common shares (“Shares”). The NCIB will be made in accordance with the requirements of the Toronto Stock Exchange and applicable securities laws. Pursuant to the NCIB, Hudbay is authorized to acquire up to a maximum of 19,751,983 Shares, representing 5% of its issued and outstanding Shares as of May 22, 2025, for cancellation over a 12-month period. The actual number of Shares which may be purchased by Hudbay pursuant to the NCIB and the timing of such purchases will be determined by management of the Company and remains subject to a number of factors, including market conditions,...

Company announcementfor ROCKWOOL A/SRelease no. 34 – 2025to Nasdaq Copenhagen         28 May 2025 Total number of voting rights and share capital in ROCKWOOL A/S On 2 May 2025, ROCKWOOL A/S (“the Company”) completed a reduction of its share capital by nominally 4,601,300 DKK. The reduction was carried out by cancellation of treasury B shares in accordance with the resolution adopted at the Company’s Annual General Meeting on 2 April 2025. In accordance with Section 32 of the Danish Capital Market Act, the Company is required to disclose the total number of voting rights and shares in the event of changes. Following completion and registration of the capital reduction, the Company’s share capital and total number of voting rights are as follows:  Share capital (nominal value, DKK) Number of shares (of 1 DKK each) Number of votesClass...

RESTON, Va., May 28, 2025 (GLOBE NEWSWIRE) — Comscore, Inc. (NASDAQ: SCOR), a global leader in measuring and analyzing consumer behavior, today announced an expansion of its partnership with Yahoo DSP, adding Comscore’s AI powered ID-free audiences to Yahoo’s existing suite of targeting solutions. As third-party signals continue to disappear and the media industry braces for the next wave of privacy regulation, these AI-powered audiences offer a privacy-centric approach for reaching consumers without relying on traditional identifiers, building on the trusted contextual segments and brand safety audiences already available in the buy-side platform. This is particularly impactful for highly regulated industries, such as health, pharma, and financial services. Through this integration, Yahoo DSP clients can now activate Comscore’s...

Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial Stands out as rare award with less than 100 clinical trials covered annually DENVER, May 28, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has agreed to pay for certain expenses incurred by medical centers treating patients covered by Medicare or Medicaid who are enrolled in the NEUTRALIZE-CRS investigational clinical trial. This follows the company’s first award for reimbursement by the CMS that was granted in July 2024 for qualified...

NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to CAN-2409 (aglatimagene besadenovec), the Company’s biological immunotherapy lead candidate, for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease. CAN-2409 was also previously granted FDA Fast Track designation for the same indication. The FDA’s RMAT designation is intended to expedite the development and review of regenerative medicine therapies intended to treat, modify, reverse, or cure...

Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company’s Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders’ Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s 2025 Proxy Statement’s compensation tables and any related information found in such proxy statement and voted to approved the appointment of Rosenberg...